Paracetamol

Paracetamol works by inhibiting cyclooxygenase enzymes in the central nervous system, which reduces the production of prostaglandins involved in pain signaling and temperature regulation. This central action lowers the perception of pain and resets the hypothalamic set‑point for body temperature.

The appropriate dose of Paracetamol is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and renal or hepatic function. Dosage regimens are individualized and should follow the prescriber’s instructions and local guidelines.

Safety data for intravenous Paracetamol in pregnancy and lactation are limited. Clinicians should evaluate the potential benefits against possible risks before prescribing to pregnant or breastfeeding women, and consider alternative therapies when appropriate.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Paracetamol provides analgesic and antipyretic effects without the anti‑inflammatory activity of NSAIDs. Compared with opioids, it has a lower risk of respiratory depression and dependence. It is often chosen when a non‑opioid, non‑NSAID option is preferred, especially in patients with bleeding risk or gastrointestinal sensitivity.

Paracetamol intravenous solution should be stored at ambient temperature, protected from moisture and light, and kept in its original packaging until use. Once opened, it should be used according to the manufacturer’s stability guidelines and discarded if any discoloration or particulate matter is observed.

Paracetamol is administered intravenously by slow infusion into a vein, typically over 15 minutes, under the supervision of qualified healthcare personnel. The infusion rate and volume are determined by the prescriber and should follow institutional protocols to avoid rapid administration that could cause hypotension.

The most serious risks include severe liver injury or hepatic failure, especially with overdose or in patients with pre‑existing liver disease, and rare hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Prompt recognition and discontinuation are essential if these events occur.

Paracetamol should be avoided in patients with known severe hepatic impairment, hypersensitivity to paracetamol or its excipients, and in those taking other hepatotoxic medications at high doses. Caution is also advised for individuals with uncontrolled alcohol use or certain metabolic disorders.